These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26905411)

  • 1. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.
    Stevenson JM; Reilly JL; Harris MS; Patel SR; Weiden PJ; Prasad KM; Badner JA; Nimgaonkar VL; Keshavan MS; Sweeney JA; Bishop JR
    Transl Psychiatry; 2016 Feb; 6(2):e739. PubMed ID: 26905411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.
    Bishop JR; Reilly JL; Harris MS; Patel SR; Kittles R; Badner JA; Prasad KM; Nimgaonkar VL; Keshavan MS; Sweeney JA
    Psychopharmacology (Berl); 2015 Jan; 232(1):145-54. PubMed ID: 25096017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
    Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
    Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
    Fijal BA; Kinon BJ; Kapur S; Stauffer VL; Conley RR; Jamal HH; Kane JM; Witte MM; Houston JP
    Pharmacogenomics J; 2009 Oct; 9(5):311-8. PubMed ID: 19451915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.
    Yu H; Yan H; Wang L; Li J; Tan L; Deng W; Chen Q; Yang G; Zhang F; Lu T; Yang J; Li K; Lv L; Tan Q; Zhang H; Xiao X; Li M; Ma X; Yang F; Li L; Wang C; Li T; Zhang D; Yue W;
    Lancet Psychiatry; 2018 Apr; 5(4):327-338. PubMed ID: 29503163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
    Houston JP; Kohler J; Bishop JR; Ellingrod VL; Ostbye KM; Zhao F; Conley RR; Poole Hoffmann V; Fijal BA
    J Clin Psychiatry; 2012 Aug; 73(8):1077-86. PubMed ID: 22967772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches.
    Ikeda M; Tomita Y; Mouri A; Koga M; Okochi T; Yoshimura R; Yamanouchi Y; Kinoshita Y; Hashimoto R; Williams HJ; Takeda M; Nakamura J; Nabeshima T; Owen MJ; O'Donovan MC; Honda H; Arinami T; Ozaki N; Iwata N
    Biol Psychiatry; 2010 Feb; 67(3):263-9. PubMed ID: 19850283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.
    Zhang JP; Robinson DG; Gallego JA; John M; Yu J; Addington J; Tohen M; Kane JM; Malhotra AK; Lencz T
    Schizophr Bull; 2015 Nov; 41(6):1248-55. PubMed ID: 26320194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia.
    Liang W; Yu H; Su Y; Lu T; Yan H; Yue W; Zhang D
    Transl Psychiatry; 2020 Mar; 10(1):83. PubMed ID: 32127521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients.
    Wei Z; Wang L; Xuan J; Che R; Du J; Qin S; Xing Y; Gu B; Yang L; Li H; Li J; Feng G; He L; Xing Q
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):547-51. PubMed ID: 19233240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.
    Keedy SK; Bishop JR; Weiden PJ; Sweeney JA; Rosen C; Marvin R; Reilly JL
    Schizophr Res; 2014 Oct; 159(1):101-6. PubMed ID: 25112158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.
    Shibata H; Tani A; Chikuhara T; Kikuta R; Sakai M; Ninomiya H; Tashiro N; Iwata N; Ozaki N; Fukumaki Y
    Psychiatry Res; 2009 May; 167(1-2):88-96. PubMed ID: 19351574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of genome-wide association studies of antipsychotic response.
    Allen JD; Bishop JR
    Pharmacogenomics; 2019 Mar; 20(4):291-306. PubMed ID: 30883267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis.
    Nelson CLM; Amsbaugh HM; Reilly JL; Rosen C; Marvin RW; Ragozzino ME; Bishop JR; Sweeney JA; Hill SK
    Schizophr Res; 2018 Dec; 202():212-216. PubMed ID: 29941295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients.
    Zhou W; Chang W; Yan Y; Shen L; Li W; Yi Z; Qin S
    Neurosci Lett; 2018 Sep; 683():202-206. PubMed ID: 30081060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.
    Kaur H; Jajodia A; Grover S; Baghel R; Jain S; Kukreti R
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):635-46. PubMed ID: 25209194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.
    Chen X; Long F; Cai B; Chen X; Chen G
    J Comp Neurol; 2018 Jan; 526(1):59-79. PubMed ID: 28856687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.